Literature DB >> 12908978

Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures.

Neil M Ferguson1, Christl A Donnelly.   

Abstract

We extended an existing back-calculation model to analyse data on reported clinical cases of bovine spongiform encephalopathy (BSE), data from random testing of healthy animals slaughtered in abattoirs and testing data from animals reported as sick or dying on the farm. Extensive analysis of demographic data was also undertaken. We estimated past and current BSE infection prevalences in the cattle population and the degree of case under-ascertainment resulting from excess mortality in cattle near to disease onset. Ongoing levels of human exposure to BSE infectivity were also estimated, together with the effect on these of a range of possible exposure-reduction strategies that might replace the current rule banning tissue from cattle over 30 months (OTM) of age from the human food supply. While any policy change that allows a wider age range of animals into the human food supply will increase levels of human exposure to infectivity, the risk posed by such increases is small by comparison with historical exposure levels. Making the pessimistic assumption that there will be 5000 deaths during the variant Creutzfeldt-Jakob disease (vCJD) epidemic in total, our analysis indicates that replacement of the OTM rule with testing would result in 0.04 additional vCJD deaths over the next 60 years. However, there is substantial (more than 40-fold) uncertainty surrounding this estimate, the sources of which are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12908978      PMCID: PMC1691417          DOI: 10.1098/rspb.2003.2484

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  9 in total

1.  The epidemiology of BSE in cattle herds in Great Britain. I. Epidemiological processes, demography of cattle and approaches to control by culling.

Authors:  C A Donnelly; N M Ferguson; A C Ghani; M E Woolhouse; C J Watt; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-07-29       Impact factor: 6.237

2.  The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics.

Authors:  N M Ferguson; C A Donnelly; M E Woolhouse; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-07-29       Impact factor: 6.237

3.  Estimation of the incidence of HIV infection.

Authors:  V Isham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1989-09-05       Impact factor: 6.237

4.  A novel progressive spongiform encephalopathy in cattle.

Authors:  G A Wells; A C Scott; C T Johnson; R F Gunning; R D Hancock; M Jeffrey; M Dawson; R Bradley
Journal:  Vet Rec       Date:  1987-10-31       Impact factor: 2.695

5.  Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels.

Authors:  Christl A Donnelly; Neil M Ferguson; Azra C Ghani; Roy M Anderson
Journal:  Proc Biol Sci       Date:  2002-11-07       Impact factor: 5.349

6.  Transmission dynamics and epidemiology of BSE in British cattle.

Authors:  R M Anderson; C A Donnelly; N M Ferguson; M E Woolhouse; C J Watt; H J Udy; S MaWhinney; S P Dunstan; T R Southwood; J W Wilesmith; J B Ryan; L J Hoinville; J E Hillerton; A R Austin; G A Wells
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

7.  Predictability of the UK variant Creutzfeldt-Jakob disease epidemic.

Authors:  J N d'Aignaux; S N Cousens; P G Smith
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

8.  Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK.

Authors:  Azra C Ghani; Neil M Ferguson; Christl A Donnelly; Roy M Anderson
Journal:  Proc Biol Sci       Date:  2003-04-07       Impact factor: 5.349

9.  Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States.

Authors:  R Brookmeyer; M H Gail
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

  9 in total
  10 in total

1.  Recipients of blood or blood products "at vCJD risk".

Authors:  Sheila M Bird
Journal:  BMJ       Date:  2004-01-17

2.  Prevalence of sheep infected with classical scrapie in Great Britain: integrating multiple sources of surveillance data for 2002.

Authors:  Simon Gubbins
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

Review 3.  The role of mathematical modelling in understanding the epidemiology and control of sheep transmissible spongiform encephalopathies: a review.

Authors:  Simon Gubbins; Suzanne Touzeau; Thomas J Hagenaars
Journal:  Vet Res       Date:  2010-02-23       Impact factor: 3.683

4.  Modelling studies on bovine spongiform encephalopathy occurrence to assist in the review of the over 30 months rule in Great Britain.

Authors:  Mark Arnold; John Wilesmith
Journal:  Proc Biol Sci       Date:  2003-10-22       Impact factor: 5.349

5.  Quantifying the risk from ovine BSE and the impact of control strategies.

Authors:  Helen R Fryer; Matthew Baylis; Kumar Sivam; Angela R McLean
Journal:  Proc Biol Sci       Date:  2007-06-22       Impact factor: 5.349

6.  There is no safe dose of prions.

Authors:  Helen R Fryer; Angela R McLean
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

7.  Impact of regulatory perturbations to disease spread through cattle movements in Great Britain.

Authors:  Matthew C Vernon; Matt J Keeling
Journal:  Prev Vet Med       Date:  2012-02-08       Impact factor: 2.670

8.  Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period.

Authors:  Mark Edward Arnold; Stephen Anthony Charles Hawkins; Robert Green; Ian Dexter; Gerald Arthur Henry Wells
Journal:  Vet Res       Date:  2008-10-28       Impact factor: 3.683

9.  Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.

Authors:  Chu-Chih Chen; Yin-Han Wang
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 10.  The economic value of One Health in relation to the mitigation of zoonotic disease risks.

Authors:  Barbara Häsler; William Gilbert; Bryony Anne Jones; Dirk Udo Pfeiffer; Jonathan Rushton; Martin Joachim Otte
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.